HK Stock Market Move | WUXI BIO(02269) rose more than 6% in early trading. The company announced plans to repurchase company shares for up to $400 million.

date
10:55 26/05/2026
avatar
GMT Eight
WuXi AppTec (02269) rose more than 6% in the morning session, with a 5.87% increase as of the time of submission, reaching HK$34.64, with a turnover of HK$880 million.
WUXI BIO (02269) rose more than 6% in the early session, rising 5.87% as of the time of writing, to 34.64 Hong Kong dollars, with a trading volume of 8.84 billion Hong Kong dollars. On the news front, WUXI BIO announced that the company has resolved to use the buyback authorization to repurchase shares in the open market at a total price not exceeding $400 million. According to the buyback authorization granted by shareholders at the annual general meeting, the company is allowed to repurchase up to 407 million shares. Xiangcai Securities stated that according to the latest 2025 annual report and 2026 Q1 data disclosed by major CXO companies, industry orders continue to grow steadily on the basis of the previous improvement, with more prominent structural highlights. China Securities Co., Ltd. pointed out that out of 94 Chinese studies selected for oral presentation at the 2026 ASCO Annual Meeting, Yervoy monoclonal antibody was showcased, marking a new milestone in the global academic influence of Chinese innovative drugs.